Follow us on LinkedIn for updates:
🔬 Startup and Scaleup Pitching Event at Bio3‑2025 ForumÂ
Are you building an early-stage or scaling biotech, medtech, or digital health company with the potential to transform healthcare and life sciences? Apply to pitch at the Startup and Scaleup Pitching Event, of the Bio3 Forum 2025, and showcase your innovation to leading investors and industry experts.Â
Date: September 17, 2025
Location: Technopolis City of Athens (Bio3 Forum, Sept 15–19)Â
We are looking for ambitious startups and scaleups that are:
Developing technologies in biotech, medtech, digital health, diagnostics, or synthetic biology
Innovating in agri/food tech, microbiome, health AI, or precision medicine
Currently raising a pre-seed, seed, or Series A or growth-stage round
Whether you’re spinning out of a university lab or preparing for your first institutional rounds, or scaling towards series B, the Bio3 forum offers a powerful platform to gain visibility and attract investor interest.
Present to a panel of VCs, angel investors, and industry experts
Gain real-time feedback on your business model, technology, and growth strategy
Connect with a dynamic network of biotech stakeholders, mentors, and potential collaborators
Be featured in the Bio3 startup and scaleup spotlight, attended by corporates, researchers, and policymakers
Submit your application for the Bio3 Startup and Scaleup Pitching by August 1, 2025
Prepare a short deck and executive summary (guidelines available on the application page)
Finalists will be notified on a rolling basis and invited to pitch on-site during Bio3
Bio3 Forum brings together the region’s most promising biotech ventures with seasoned investors and global industry leaders. By combining the Bio3 Pitching Event with the long-term vision of investors, we are cultivating a pipeline of high-impact companies ready to shape the future of health and life sciences, in Greece and beyond.
Apply now to pitch your startup or scaleup and become part of the next generation of biotech disruptors at Bio3‑2025.